These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8653412)

  • 1. Alpha 2-adrenoceptor agonist, dexmedetomidine, protects against kainic acid-induced convulsions and neuronal damage.
    Halonen T; Kotti T; Tuunanen J; Toppinen A; Miettinen R; Riekkinen PJ
    Brain Res; 1995 Sep; 693(1-2):217-24. PubMed ID: 8653412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vigabatrin protects against kainic acid-induced neuronal damage in the rat hippocampus.
    Halonen T; Miettinen R; Toppinen A; Tuunanen J; Kotti T; Riekkinen PJ
    Neurosci Lett; 1995 Jul; 195(1):13-6. PubMed ID: 7478243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexmedetomidine protects neurons from kainic acid-induced excitotoxicity by activating BDNF signaling.
    Chiu KM; Lin TY; Lee MY; Lu CW; Wang MJ; Wang SJ
    Neurochem Int; 2019 Oct; 129():104493. PubMed ID: 31220473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of vigabatrin treatment on status epilepticus-induced neuronal damage and mossy fiber sprouting in the rat hippocampus.
    Pitkänen A; Nissinen J; Jolkkonen E; Tuunanen J; Halonen T
    Epilepsy Res; 1999 Jan; 33(1):67-85. PubMed ID: 10022367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of alpha 2-adrenergic drugs dexmedetomidine and atipamezole on extracellular amino acid levels in vivo.
    Valtonen P; Haapalinna A; Riekkinen P; Halonen T
    Eur J Pharmacol; 1995 Oct; 285(3):239-46. PubMed ID: 8575509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of ethanol-induced sympathetic overactivity and degeneration by dexmedetomidine.
    Jaatinen P; Riihioja P; Haapalinna A; Heinonen E; Kiianmaa K; Hervonen A
    Alcohol; 1995; 12(5):439-46. PubMed ID: 8519439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexmedetomidine reduces response tendency, but not accuracy of rats in attention and short-term memory tasks.
    Ruotsalainen S; Haapalinna A; Riekkinen PJ; Sirviö J
    Pharmacol Biochem Behav; 1997 Jan; 56(1):31-40. PubMed ID: 8981606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroendocrine effects of dexmedetomidine: evidence of cross-tolerance between a mu-opioid agonist and an alpha 2-adrenoceptor agonist in growth hormone secretion of the male rat.
    Idänpään-Heikkilä JJ; Rauhala P; Männistö PT
    Pharmacol Toxicol; 1996 Mar; 78(3):136-42. PubMed ID: 8882345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid reversal of alpha 2-adrenoceptor agonist effects by atipamezole in human volunteers.
    Karhuvaara S; Kallio A; Salonen M; Tuominen J; Scheinin M
    Br J Clin Pharmacol; 1991 Feb; 31(2):160-5. PubMed ID: 1675577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NA+, K+-ATPase activity in the brain of the rats with kainic acid-induced seizures: influence of lamotrigine.
    Vitezić D; Pelcić JM; Zupan G; Vitezić M; Ljubicić D; Simonić A
    Psychiatr Danub; 2008 Sep; 20(3):269-76. PubMed ID: 18827752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha 2-adrenoceptor-mediated inhibition of gastric acid secretion by medetomidine is efficiently antagonized by atipamezole in rats.
    Savola M; Savola JM; Puurunen J
    Arch Int Pharmacodyn Ther; 1989; 301():267-76. PubMed ID: 2576195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The alpha 2-adrenoceptor antagonist atipamezole potentiates anti-Parkinsonian effects and can reduce the adverse cardiovascular effects of dopaminergic drugs in rats.
    Haapalinna A; Leino T; Heinonen E
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Nov; 368(5):342-51. PubMed ID: 14566451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective effects of anti-high-mobility group box 1 antibody in juvenile rat hippocampus after kainic acid-induced status epilepticus.
    Li Z; Li B; Zhu X; Yin P; Liu J; Huang S; Sun R
    Neuroreport; 2013 Oct; 24(14):785-90. PubMed ID: 23839305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular actions of medetomidine and their reversal by atipamezole.
    Savola JM
    Acta Vet Scand Suppl; 1989; 85():39-47. PubMed ID: 2571276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial dysfunction and ultrastructural damage in the hippocampus during kainic acid-induced status epilepticus in the rat.
    Chuang YC; Chang AY; Lin JW; Hsu SP; Chan SH
    Epilepsia; 2004 Oct; 45(10):1202-9. PubMed ID: 15461674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroalcoholic extract of Emblica officinalis protects against kainic acid-induced status epilepticus in rats: evidence for an antioxidant, anti-inflammatory, and neuroprotective intervention.
    Golechha M; Bhatia J; Ojha S; Arya DS
    Pharm Biol; 2011 Nov; 49(11):1128-36. PubMed ID: 21749189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexmedetomidine, a selective alpha 2-agonist, does not potentiate the cardiorespiratory depression of alfentanil in the rat.
    Furst SR; Weinger MB
    Anesthesiology; 1990 May; 72(5):882-8. PubMed ID: 1971163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotection by the alpha2-adrenoceptor agonist, dexmedetomidine, in rat focal cerebral ischemia.
    Jolkkonen J; Puurunen K; Koistinaho J; Kauppinen R; Haapalinna A; Nieminen L; Sivenius J
    Eur J Pharmacol; 1999 May; 372(1):31-6. PubMed ID: 10374712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexmedetomidine stops benzodiazepine-refractory nerve agent-induced status epilepticus.
    McCarren HS; Arbutus JA; Ardinger C; Dunn EN; Jackson CE; McDonough JH
    Epilepsy Res; 2018 Mar; 141():1-12. PubMed ID: 29414381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment with antiepileptic drugs: possible neuroprotective effects.
    Pitkänen A
    Neurology; 1996 Jul; 47(1 Suppl 1):S12-6. PubMed ID: 8677031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.